ESR1 and breast cancer: Interestingly, miRNA expression is regulated by ERα and these findings suggest that the activity of this regulatory loop may confer proliferative advantage and migratory activity to breast cancer cells and promote the transition from ER-positive to ER-negative tumors [30].